A Study of Brentuximab Vedotin in Relapsed or Refractory Non-Hodgkin Lymphoma

NYU Clinical Cancer Center, New York

Columbia University Medical Center, New York

Memorial Sloan Kettering Cancer Center, New York

New York Oncology Hematology, P.C., Albany

Virginia Cancer Specialists, PC, Fairfax

Medical University of South Carolina, Charleston

St. Francis Hospital, Greenville

Emory Winship Cancer Institute, Atlanta

Cancer Specialists of North Florida - St. Augustine, Saint Augustine

Cleveland Clinic, The, Cleveland

Minnesota Oncology Hematology P.A., Minneapolis

Northwestern University, Chicago

Washington University School of Medicine, St Louis

Texas Oncology - Medical City Dallas, Dallas

Charles A. Sammons Cancer Center, Dallas

Texas Oncology - Tyler, Tyler

Texas Oncology-Southwest Fort Worth, Fort Worth

Texas Oncology - Seton Williamson, Round Rock

Rocky Mountain Cancer Centers - Aurora, Aurora

Colorado Blood Cancer Institute, Denver

Comprehensive Cancer Centers of Nevada, Las Vegas

PMK Medical Group Inc., DBA Ventura County Hematology Oncology Specialists, Oxnard

Willamette Valley Cancer and Research / USOR, Eugene

Swedish Cancer Institute Medical Oncology, Edmonds

Seattle Cancer Care Alliance / University of Washington Medical Center, Seattle

Northwest Cancer Specialists, P.C., Vancouver

University of Alabama at Birmingham, Birmingham

City of Hope, Duarte

Stanford Cancer Center, Stanford

University of Chicago, Chicago

Dana-Farber Cancer Institute, Boston

Hackensack University Medical Center, Hackensack

MD Anderson Cancer Center / University of Texas, Houston

British Columbia Cancer Agency - Vancouver Centre, Vancouver